Vonoprazan is a first-in-class potassium-competitive acid blocker medication. It was approved in the Japanese market in February 2015 and in Russia in April 2021. Vonoprazan is used in the form of fumarate for the treatment of gastroduodenal ulcers (including some drug-induced peptic ulcers) and reflux esophagitis and can be combined with antibiotics for the eradication …
↧